{
  "nct_id": "NCT58940370",
  "indication": "Rheumatoid Arthritis",
  "phase": "Phase 3",
  "sample_size": 861,
  "duration_weeks": 45,
  "dropout_rate": 0.28,
  "blinding": "open-label",
  "control_arm": "placebo",
  "primary_endpoints": [
    "ACR20 response"
  ],
  "secondary_endpoints": [
    "DAS28 score reduction",
    "HAQ-DI improvement"
  ],
  "outcome_summary": "Study terminated early due to futility",
  "success": 0,
  "failure_reason": "Drug-drug interactions affected efficacy",
  "start_date": "2020-08-28",
  "completion_date": "2021-07-09"
}